Your browser doesn't support javascript.
loading
Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial.
Kawahara, Takuya; Taira, Naruto; Shiroiwa, Takeru; Hagiwara, Yasuhiro; Fukuda, Takashi; Uemura, Yukari; Mukai, Hirofumi.
Afiliación
  • Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. takuyakawahara@g.ecc.u-tokyo.ac.jp.
  • Taira N; Breast and Endocrine Surgery Department, Okayama University Hospital, Okayama, Japan.
  • Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
  • Hagiwara Y; Department of Biostatistics, Division of Health Sciences and Nursing, The University of Tokyo, Tokyo, Japan.
  • Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
  • Uemura Y; Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Qual Life Res ; 31(6): 1829-1836, 2022 Jun.
Article en En | MEDLINE | ID: mdl-34982354

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón